News · 26 weeks3+100%
2026-03-012026-08-23
Mix390d
- Offering2(67%)
- Other1(33%)
Latest news
25 items- PRAttovia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesSAN CARLOS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. ("Attovia") (NASDAQ:ATTO), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need, today announced the closing of its upsized initial public offering of 19,550,000 shares of its common stock, which includes the exercise in full by the underwriters of their option to purchase 2,550,000 additional shares, at the initial public offering price of $17.00 per share. The aggregate gross proceeds to Attovia from the initial public offering were approximately $332.4 million, before deducting underwriting discounts and commissions and other
- PRImmune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on NasdaqSHANGHAI, Aug. 6, 2026 /PRNewswire/ -- Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (NASDAQ:ATTO) issued shares at a price of $17.00 per share and opened at $21.00 per share, with an approximate market capitalization of $904 million. Commencing operations in 2023, Attovia develops next‑generation biotherapeutics for immune‑mediated diseases with high unmet medical needs. All of Attovia's product candidates are discovered on its ATTOBODY biologics platform, which is licensed under an exclusive worldwide license from Alamar Biosciences, als
- PRAttovia Therapeutics Announces Pricing of Upsized Initial Public OfferingSAN CARLOS, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. ("Attovia") (NASDAQ:ATTO), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need, today announced the pricing of its upsized initial public offering of 17,000,000 shares of its common stock at an initial public offering price of $17.00 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be $289.0 million. All shares of common stock to be sold in the offering will be sold by Attovia. In addition, Attovia has granted the underwriters a
- SECSEC Form 6-K filed by Atento S.A.6-K - Atento S.A. (0001606457) (Filer)
- SECSEC Form 6-K filed by Atento S.A.6-K - Atento S.A. (0001606457) (Filer)
- SECSEC Form 6-K filed by Atento S.A.6-K - Atento S.A. (0001606457) (Filer)
- SECSEC Form 6-K filed by Atento S.A.6-K - Atento S.A. (0001606457) (Filer)
- SECSEC Form 6-K filed by Atento S.A.6-K - Atento S.A. (0001606457) (Filer)
- SECSEC Form 6-K filed by Atento S.A.6-K - Atento S.A. (0001606457) (Filer)
- SECSEC Form 6-K filed by Atento S.A.6-K - Atento S.A. (0001606457) (Filer)
- SECSEC Form 25-NSE filed by Atento S.A.25-NSE - Atento S.A. (0001606457) (Subject)
- PRAtento announces drawdown of $17 million in tranche 2 funding under its new interim financingTranche 2 upsized by $7 million to provide enhanced financial runway to support Atento's restructuring following substantial interest from existing investorsParticipation in Tranche 2 reflects incremental support for the Restructuring Support AgreementUpsizing of Tranche 2 financing brings total committed interim funding to the $37 million originally contemplatedNEW YORK, Aug. 1, 2023 /PRNewswire/ -- Atento S.A. (NYSE:ATTO, ", Atento", or the ", Company", ))), one of the world's largest providers of customer relationship and business process outsourcing (CRM/BPO) services and an industry leader in Latin America, today announced that it has received $17 million in tranche 2 funding under its
- SECSEC Form 6-K filed by Atento S.A.6-K - Atento S.A. (0001606457) (Filer)
- SECSEC Form EFFECT filed by Atento S.A.EFFECT - Atento S.A. (0001606457) (Filer)
- SECSEC Form POS AM filed by Atento S.A.POS AM - Atento S.A. (0001606457) (Filer)
- SECSEC Form S-8 POS filed by Atento S.A.S-8 POS - Atento S.A. (0001606457) (Filer)
- SECSEC Form S-8 POS filed by Atento S.A.S-8 POS - Atento S.A. (0001606457) (Filer)
- SECSEC Form F-3/A filed by Atento S.A. (Amendment)F-3/A - Atento S.A. (0001606457) (Filer)
- PRAtento Announces Delisting from NYSE; Delisting expected in Restructuring PlanDelisting is contemplated by the previously announced comprehensive financial restructuring plan aimed at optimizing financial and operational efficiency and driving long-term growth. Delisting affects only the shares of Atento S.A. at a holding company level so will not affect business operations.NEW YORK, July 21, 2023 /PRNewswire/ -- Atento S.A. (NYSE:ATTO, ", Atento", or the ", Company", ))), one of the world's largest providers of customer relationship and business process outsourcing (CRM/BPO) services and an industry leader in Latin America, today announced that it received notification from the New York Stock Exchange ("NYSE") that the NYSE has initiated proceedings to delist Atento'
- SECSEC Form 6-K filed by Atento S.A.6-K - Atento S.A. (0001606457) (Filer)
- NEWSNYSE To Commence Delisting Proceedings Against Atento S.A.The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the ordinary shares of Atento S.A. (the “Company”) — ticker symbol ATTO — from the NYSE. Trading in the Company’s ordinary shares will be suspended immediately. NYSE Regulation reached its decision to delist the Company’s ordinary shares pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive 30 trading day period of at least $15,000,000. The Company has a right
- NEWSAtento S.A. Shares Halted, News Pending
- NEWSShares of indsutrial stocks are trading lower amid overall market weakness on rate hike concerns. Further rate hikes could pressure economic activity and spending.
- SECSEC Form 6-K filed by Atento S.A.6-K - Atento S.A. (0001606457) (Filer)
- SECSEC Form 6-K filed by Atento S.A.6-K - Atento S.A. (0001606457) (Filer)
ATTO FAQ
7 questionsWhat does Atento S.A. do?
Atento S.A., together with its subsidiaries, provides customer relationship management, and business process outsourcing services and solutions in Brazil, the Americas, Europe, the Middle East, and Africa. It offers a range of front and back-end services, including sales, customer care, technical support, collections, and back office, as well as applications-processing and credit-management. The company serves clients primarily in the telecommunications, banking, and financial services sectors; and in multi-sectors, including consumer goods, services, public administration, travel...Where does ATTO stock trade?
Atento S.A. (ATTO) is listed on NYSE.What sector and industry is ATTO in?
Atento S.A. operates in the Telecommunications sector, Telecommunications Equipment industry.When did Atento S.A. go public?
Atento S.A. (ATTO) completed its IPO in 2014.What are analysts saying about ATTO?
Atento S.A. has had 1 recent analyst action on file. The most recent action was from Goldman Sachs: Neutral with a $3000.00 price target on 2021-09-21. Recent price targets cluster around $3000.00.What companies are similar to ATTO?
Notable peers in the same industry include VZ (Verizon Communications Inc.), TMUS (T-Mobile US Inc.), T (AT&T Inc.), GLW (Corning Incorporated), LITE (Lumentum Holdings Inc.). Compare ATTO side-by-side with any of them on Quantisnow.How can I track ATTO on Quantisnow?
Quantisnow aggregates Atento S.A.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ATTO to receive live email and push alerts on every new disclosure.